| answer text |
<p>PrescQIPP is an independent social enterprise and any decision to withdraw this
guidance is a matter for PrescQIPP.</p><p>Clinical commissioning groups (CCGs) are
responsible for deciding whether and how they take that guidance into account when
making decisions. However, NHS England expects CCGs to have due regard to the <em>Items
which should not routinely be prescribed in primary care: Guidance for CCGs</em> published
in November 2017 by NHS England and NHS Clinical Commissioners when considering the
prescribing of liothyronine. A copy of the guidance is attached.</p>
|
 |
